RTK Group, LLC, ("RTK Group"), an early-stage advisory and investment fund supporting emerging technologies in the biotech and pharmaceutical sector, today announced its participation in seed-round capital funding of Unravel Biosciences, Inc. ("Unravel").  Financial terms of the transaction were not disclosed.

BD Biosciences provides flow cytometers, reagents, tools, and a wide range of services to support the work of researchers and clinicians who understand disease and improve care.

Rtk Group Announces Investment In Unravel Biosciences

Description

Company Information

Rtk Group Announces Investment In Unravel Biosciences

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information